APO Research
Talk to an analyst

APO RESEARCH · REPORT

DNA Repair Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global DNA Repair Drugs Market Analysis and Forecast 2026-2032

19 December 2025201 pages

Choose your research edition.

Industry ResearchDNA Repair Drugs Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal DNA Repair Drugs Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal DNA Repair Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DNA Repair Drugs Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal DNA Repair Drugs Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global DNA Repair Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for DNA Repair Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for DNA Repair Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for DNA Repair Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for DNA Repair Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of DNA Repair Drugs include Johnson & Johnson, Jiangsu Hengrui Medicine, GlaxoSmithKline, Tesaro, National Institutes of Health, National Health Service, KuDOS Pharmaceuticals, Karyopharm Therapeutics and Jonsson Comprehensive Cancer Center, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for DNA Repair Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of DNA Repair Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for DNA Repair Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the DNA Repair Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global DNA Repair Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for DNA Repair Drugs sales, projected growth trends, production technology, application and end-user industry.

DNA Repair Drugs Segment by Company

Johnson & Johnson

Jiangsu Hengrui Medicine

GlaxoSmithKline

Tesaro

National Institutes of Health

National Health Service

KuDOS Pharmaceuticals

Karyopharm Therapeutics

Jonsson Comprehensive Cancer Center

German Breast Group

Georgetown University

Genentech

Cambridge University Hospitals NHS Foundation Trust

British Columbia Cancer Agency

Bristol Myers Squibb

ARCAGY/ GINECO GROUP

4SC AG

DNA Repair Drugs Segment by Type

PARP Inhibitors

Other

DNA Repair Drugs Segment by Application

Oncological

Stroke

DNA Repair Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Repair Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DNA Repair Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Repair Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of DNA Repair Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of DNA Repair Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, DNA Repair Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global DNA Repair Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. PARP Inhibitors Major Manufacturers Table 3. Other Major Manufacturers Table 4. Global DNA Repair Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Oncological Major Manufacturers Table 6. Stroke Major Manufacturers Table 7. DNA Repair Drugs Industry Trends Table 8. DNA Repair Drugs Industry Drivers Table 9. DNA Repair Drugs Industry Opportunities and Challenges Table 10. DNA Repair Drugs Industry Restraints Table 11. Global DNA Repair Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global DNA Repair Drugs Revenue by Region (2021-2026) & (US$ Million) Table 13. Global DNA Repair Drugs Revenue by Region (2027-2032) & (US$ Million) Table 14. Global DNA Repair Drugs Revenue Market Share by Region (2021-2026) Table 15. Global DNA Repair Drugs Revenue Market Share by Region (2027-2032) Table 16. Global DNA Repair Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global DNA Repair Drugs Sales by Region (2021-2026) & (K Units) Table 18. Global DNA Repair Drugs Sales by Region (2027-2032) & (K Units) Table 19. Global DNA Repair Drugs Sales Market Share by Region (2021-2026) Table 20. Global DNA Repair Drugs Sales Market Share by Region (2027-2032) Table 21. Global DNA Repair Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global DNA Repair Drugs Revenue Market Share by Manufacturers (2021-2026) Table 23. Global DNA Repair Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global DNA Repair Drugs Sales Market Share by Manufacturers (2021-2026) Table 25. Global DNA Repair Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global DNA Repair Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global DNA Repair Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global DNA Repair Drugs Manufacturers, Product Type & Application Table 29. Global DNA Repair Drugs Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global DNA Repair Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global DNA Repair Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global DNA Repair Drugs Revenue by Type (2021-2026) & (US$ Million) Table 34. Global DNA Repair Drugs Revenue by Type (2027-2032) & (US$ Million) Table 35. Global DNA Repair Drugs Revenue Market Share by Type (2021-2026) Table 36. Global DNA Repair Drugs Revenue Market Share by Type (2027-2032) Table 37. Global DNA Repair Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global DNA Repair Drugs Sales by Type (2021-2026) & (K Units) Table 39. Global DNA Repair Drugs Sales by Type (2027-2032) & (K Units) Table 40. Global DNA Repair Drugs Sales Market Share by Type (2021-2026) Table 41. Global DNA Repair Drugs Sales Market Share by Type (2027-2032) Table 42. Global DNA Repair Drugs Price by Type (2021-2026) & (US$/Unit) Table 43. Global DNA Repair Drugs Price by Type (2027-2032) & (US$/Unit) Table 44. Global DNA Repair Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global DNA Repair Drugs Revenue by Application (2021-2026) & (US$ Million) Table 46. Global DNA Repair Drugs Revenue by Application (2027-2032) & (US$ Million) Table 47. Global DNA Repair Drugs Revenue Market Share by Application (2021-2026) Table 48. Global DNA Repair Drugs Revenue Market Share by Application (2027-2032) Table 49. Global DNA Repair Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global DNA Repair Drugs Sales by Application (2021-2026) & (K Units) Table 51. Global DNA Repair Drugs Sales by Application (2027-2032) & (K Units) Table 52. Global DNA Repair Drugs Sales Market Share by Application (2021-2026) Table 53. Global DNA Repair Drugs Sales Market Share by Application (2027-2032) Table 54. Global DNA Repair Drugs Price by Application (2021-2026) & (US$/Unit) Table 55. Global DNA Repair Drugs Price by Application (2027-2032) & (US$/Unit) Table 56. Johnson & Johnson Company Information Table 57. Johnson & Johnson Business Overview Table 58. Johnson & Johnson DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Johnson & Johnson DNA Repair Drugs Product Portfolio Table 60. Johnson & Johnson Recent Development Table 61. Jiangsu Hengrui Medicine Company Information Table 62. Jiangsu Hengrui Medicine Business Overview Table 63. Jiangsu Hengrui Medicine DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Jiangsu Hengrui Medicine DNA Repair Drugs Product Portfolio Table 65. Jiangsu Hengrui Medicine Recent Development Table 66. GlaxoSmithKline Company Information Table 67. GlaxoSmithKline Business Overview Table 68. GlaxoSmithKline DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. GlaxoSmithKline DNA Repair Drugs Product Portfolio Table 70. GlaxoSmithKline Recent Development Table 71. Tesaro Company Information Table 72. Tesaro Business Overview Table 73. Tesaro DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Tesaro DNA Repair Drugs Product Portfolio Table 75. Tesaro Recent Development Table 76. National Institutes of Health Company Information Table 77. National Institutes of Health Business Overview Table 78. National Institutes of Health DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. National Institutes of Health DNA Repair Drugs Product Portfolio Table 80. National Institutes of Health Recent Development Table 81. National Health Service Company Information Table 82. National Health Service Business Overview Table 83. National Health Service DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. National Health Service DNA Repair Drugs Product Portfolio Table 85. National Health Service Recent Development Table 86. KuDOS Pharmaceuticals Company Information Table 87. KuDOS Pharmaceuticals Business Overview Table 88. KuDOS Pharmaceuticals DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. KuDOS Pharmaceuticals DNA Repair Drugs Product Portfolio Table 90. KuDOS Pharmaceuticals Recent Development Table 91. Karyopharm Therapeutics Company Information Table 92. Karyopharm Therapeutics Business Overview Table 93. Karyopharm Therapeutics DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Karyopharm Therapeutics DNA Repair Drugs Product Portfolio Table 95. Karyopharm Therapeutics Recent Development Table 96. Jonsson Comprehensive Cancer Center Company Information Table 97. Jonsson Comprehensive Cancer Center Business Overview Table 98. Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Jonsson Comprehensive Cancer Center DNA Repair Drugs Product Portfolio Table 100. Jonsson Comprehensive Cancer Center Recent Development Table 101. German Breast Group Company Information Table 102. German Breast Group Business Overview Table 103. German Breast Group DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. German Breast Group DNA Repair Drugs Product Portfolio Table 105. German Breast Group Recent Development Table 106. Georgetown University Company Information Table 107. Georgetown University Business Overview Table 108. Georgetown University DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Georgetown University DNA Repair Drugs Product Portfolio Table 110. Georgetown University Recent Development Table 111. Genentech Company Information Table 112. Genentech Business Overview Table 113. Genentech DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Genentech DNA Repair Drugs Product Portfolio Table 115. Genentech Recent Development Table 116. Cambridge University Hospitals NHS Foundation Trust Company Information Table 117. Cambridge University Hospitals NHS Foundation Trust Business Overview Table 118. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product Portfolio Table 120. Cambridge University Hospitals NHS Foundation Trust Recent Development Table 121. British Columbia Cancer Agency Company Information Table 122. British Columbia Cancer Agency Business Overview Table 123. British Columbia Cancer Agency DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. British Columbia Cancer Agency DNA Repair Drugs Product Portfolio Table 125. British Columbia Cancer Agency Recent Development Table 126. Bristol Myers Squibb Company Information Table 127. Bristol Myers Squibb Business Overview Table 128. Bristol Myers Squibb DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Bristol Myers Squibb DNA Repair Drugs Product Portfolio Table 130. Bristol Myers Squibb Recent Development Table 131. ARCAGY/ GINECO GROUP Company Information Table 132. ARCAGY/ GINECO GROUP Business Overview Table 133. ARCAGY/ GINECO GROUP DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. ARCAGY/ GINECO GROUP DNA Repair Drugs Product Portfolio Table 135. ARCAGY/ GINECO GROUP Recent Development Table 136. 4SC AG Company Information Table 137. 4SC AG Business Overview Table 138. 4SC AG DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. 4SC AG DNA Repair Drugs Product Portfolio Table 140. 4SC AG Recent Development Table 141. North America DNA Repair Drugs Revenue by Type (2021-2026) & (US$ Million) Table 142. North America DNA Repair Drugs Revenue by Type (2027-2032) & (US$ Million) Table 143. North America DNA Repair Drugs Sales by Type (2021-2026) & (K Units) Table 144. North America DNA Repair Drugs Sales by Type (2027-2032) & (K Units) Table 145. North America DNA Repair Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 146. North America DNA Repair Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 147. North America DNA Repair Drugs Revenue by Application (2021-2026) & (US$ Million) Table 148. North America DNA Repair Drugs Revenue by Application (2027-2032) & (US$ Million) Table 149. North America DNA Repair Drugs Sales by Application (2021-2026) & (K Units) Table 150. North America DNA Repair Drugs Sales by Application (2027-2032) & (K Units) Table 151. North America DNA Repair Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 152. North America DNA Repair Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 153. North America DNA Repair Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. North America DNA Repair Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 155. North America DNA Repair Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 156. North America DNA Repair Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 157. North America DNA Repair Drugs Sales by Country (2021-2026) & (K Units) Table 158. North America DNA Repair Drugs Sales by Country (2027-2032) & (K Units) Table 159. North America DNA Repair Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 160. North America DNA Repair Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 161. United States DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Table 162. Canada DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Table 163. Europe DNA Repair Drugs Revenue by Type (2021-2026) & (US$ Million) Table 164. Europe DNA Repair Drugs Revenue by Type (2027-2032) & (US$ Million) Table 165. Europe DNA Repair Drugs Sales by Type (2021-2026) & (K Units) Table 166. Europe DNA Repair Drugs Sales by Type (2027-2032) & (K Units) Table 167. Europe DNA Repair Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 168. Europe DNA Repair Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 169. Europe DNA Repair Drugs Revenue by Application (2021-2026) & (US$ Million) Table 170. Europe DNA Repair Drugs Revenue by Application (2027-2032) & (US$ Million) Table 171. Europe DNA Repair Drugs Sales by Application (2021-2026) & (K Units) Table 172. Europe DNA Repair Drugs Sales by Application (2027-2032) & (K Units) Table 173. Europe DNA Repair Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 174. Europe DNA Repair Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 175. Europe DNA Repair Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. Europe DNA Repair Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. Europe DNA Repair Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. Europe DNA Repair Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 179. Europe DNA Repair Drugs Sales by Country (2021-2026) & (K Units) Table 180. Europe DNA Repair Drugs Sales by Country (2027-2032) & (K Units) Table 181. Europe DNA Repair Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 182. Europe DNA Repair Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 183. Germany DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Table 184. France DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Table 185. U.K. DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Table 186. Italy DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Table 187. Netherlands DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Table 188. Nordic Countries DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Table 189. China DNA Repair Drugs Revenue by Type (2021-2026) & (US$ Million) Table 190. China DNA Repair Drugs Revenue by Type (2027-2032) & (US$ Million) Table 191. China DNA Repair Drugs Sales by Type (2021-2026) & (K Units) Table 192. China DNA Repair Drugs Sales by Type (2027-2032) & (K Units) Table 193. China DNA Repair Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 194. China DNA Repair Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 195. China DNA Repair Drugs Revenue by Application (2021-2026) & (US$ Million) Table 196. China DNA Repair Drugs Revenue by Application (2027-2032) & (US$ Million) Table 197. China DNA Repair Drugs Sales by Application (2021-2026) & (K Units) Table 198. China DNA Repair Drugs Sales by Application (2027-2032) & (K Units) Table 199. China DNA Repair Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 200. China DNA Repair Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 201. Asia DNA Repair Drugs Revenue by Type (2021-2026) & (US$ Million) Table 202. Asia DNA Repair Drugs Revenue by Type (2027-2032) & (US$ Million) Table 203. Asia DNA Repair Drugs Sales by Type (2021-2026) & (K Units) Table 204. Asia DNA Repair Drugs Sales by Type (2027-2032) & (K Units) Table 205. Asia DNA Repair Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 206. Asia DNA Repair Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 207. Asia DNA Repair Drugs Revenue by Application (2021-2026) & (US$ Million) Table 208. Asia DNA Repair Drugs Revenue by Application (2027-2032) & (US$ Million) Table 209. Asia DNA Repair Drugs Sales by Application (2021-2026) & (K Units) Table 210. Asia DNA Repair Drugs Sales by Application (2027-2032) & (K Units) Table 211. Asia DNA Repair Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 212. Asia DNA Repair Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 213. Asia DNA Repair Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 214. Asia DNA Repair Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 215. Asia DNA Repair Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 216. Asia DNA Repair Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 217. Asia DNA Repair Drugs Sales by Country (2021-2026) & (K Units) Table 218. Asia DNA Repair Drugs Sales by Country (2027-2032) & (K Units) Table 219. Asia DNA Repair Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 220. Asia DNA Repair Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 221. Japan DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Table 222. South Korea DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Table 223. India DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Table 224. Australia DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Table 225. China Taiwan DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Table 226. Southeast Asia DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Table 227. SAMEA DNA Repair Drugs Revenue by Type (2021-2026) & (US$ Million) Table 228. SAMEA DNA Repair Drugs Revenue by Type (2027-2032) & (US$ Million) Table 229. SAMEA DNA Repair Drugs Sales by Type (2021-2026) & (K Units) Table 230. SAMEA DNA Repair Drugs Sales by Type (2027-2032) & (K Units) Table 231. SAMEA DNA Repair Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 232. SAMEA DNA Repair Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 233. SAMEA DNA Repair Drugs Revenue by Application (2021-2026) & (US$ Million) Table 234. SAMEA DNA Repair Drugs Revenue by Application (2027-2032) & (US$ Million) Table 235. SAMEA DNA Repair Drugs Sales by Application (2021-2026) & (K Units) Table 236. SAMEA DNA Repair Drugs Sales by Application (2027-2032) & (K Units) Table 237. SAMEA DNA Repair Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 238. SAMEA DNA Repair Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 239. SAMEA DNA Repair Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 240. SAMEA DNA Repair Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 241. SAMEA DNA Repair Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 242. SAMEA DNA Repair Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 243. SAMEA DNA Repair Drugs Sales by Country (2021-2026) & (K Units) Table 244. SAMEA DNA Repair Drugs Sales by Country (2027-2032) & (K Units) Table 245. SAMEA DNA Repair Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 246. SAMEA DNA Repair Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 247. Brazil DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Table 248. Argentina DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Table 249. Chile DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Table 250. Colombia DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Table 251. Peru DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Table 252. Saudi Arabia DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Table 253. Israel DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Table 254. UAE DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Table 255. Turkey DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Table 256. Iran DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Table 257. Egypt DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Table 258. Key Raw Materials Table 259. Raw Materials Key Suppliers Table 260. DNA Repair Drugs Distributors List Table 261. DNA Repair Drugs Customers List Table 262. Research Programs/Design for This Report Table 263. Authors List of This Report Table 264. Secondary Sources Table 265. Primary Sources List of Figures Figure 1. DNA Repair Drugs Image Figure 2. Global DNA Repair Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DNA Repair Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. PARP Inhibitors Image Figure 5. Other Image Figure 6. Global DNA Repair Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global DNA Repair Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Oncological Image Figure 9. Stroke Image Figure 10. Global DNA Repair Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Figure 12. Global DNA Repair Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global DNA Repair Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global DNA Repair Drugs Revenue Market Share by Region (2021-2032) Figure 15. Global DNA Repair Drugs Sales (2021-2032) & (K Units) Figure 16. Global DNA Repair Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global DNA Repair Drugs Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico DNA Repair Drugs Sales YoY (2021-2032) & (K Units) Figure 19. Europe DNA Repair Drugs Sales YoY (2021-2032) & (K Units) Figure 20. China DNA Repair Drugs Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) DNA Repair Drugs Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa DNA Repair Drugs Sales YoY (2021-2032) & (K Units) Figure 23. Global DNA Repair Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global DNA Repair Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global DNA Repair Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global DNA Repair Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global DNA Repair Drugs Revenue Market Share by Type (2021-2032) Figure 29. Global DNA Repair Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global DNA Repair Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global DNA Repair Drugs Sales Market Share by Type (2021-2032) Figure 32. Global DNA Repair Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global DNA Repair Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global DNA Repair Drugs Revenue Market Share by Application (2021-2032) Figure 35. Global DNA Repair Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global DNA Repair Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global DNA Repair Drugs Sales Market Share by Application (2021-2032) Figure 38. North America DNA Repair Drugs Revenue Share by Type (2021-2032) Figure 39. North America DNA Repair Drugs Sales Share by Type (2021-2032) Figure 40. North America DNA Repair Drugs Revenue Share by Application (2021-2032) Figure 41. North America DNA Repair Drugs Sales Share by Application (2021-2032) Figure 42. North America DNA Repair Drugs Revenue Share by Country (2021-2032) Figure 43. North America DNA Repair Drugs Sales Share by Country (2021-2032) Figure 44. Europe DNA Repair Drugs Revenue Share by Type (2021-2032) Figure 45. Europe DNA Repair Drugs Sales Share by Type (2021-2032) Figure 46. Europe DNA Repair Drugs Revenue Share by Application (2021-2032) Figure 47. Europe DNA Repair Drugs Sales Share by Application (2021-2032) Figure 48. Europe DNA Repair Drugs Revenue Share by Country (2021-2032) Figure 49. Europe DNA Repair Drugs Sales Share by Country (2021-2032) Figure 50. China DNA Repair Drugs Revenue Share by Type (2021-2032) Figure 51. China DNA Repair Drugs Sales Share by Type (2021-2032) Figure 52. China DNA Repair Drugs Revenue Share by Application (2021-2032) Figure 53. China DNA Repair Drugs Sales Share by Application (2021-2032) Figure 54. Asia DNA Repair Drugs Revenue Share by Type (2021-2032) Figure 55. Asia DNA Repair Drugs Sales Share by Type (2021-2032) Figure 56. Asia DNA Repair Drugs Revenue Share by Application (2021-2032) Figure 57. Asia DNA Repair Drugs Sales Share by Application (2021-2032) Figure 58. Asia DNA Repair Drugs Revenue Share by Country (2021-2032) Figure 59. Asia DNA Repair Drugs Sales Share by Country (2021-2032) Figure 60. SAMEA DNA Repair Drugs Revenue Share by Type (2021-2032) Figure 61. SAMEA DNA Repair Drugs Sales Share by Type (2021-2032) Figure 62. SAMEA DNA Repair Drugs Revenue Share by Application (2021-2032) Figure 63. SAMEA DNA Repair Drugs Sales Share by Application (2021-2032) Figure 64. SAMEA DNA Repair Drugs Revenue Share by Country (2021-2032) Figure 65. SAMEA DNA Repair Drugs Sales Share by Country (2021-2032) Figure 66. DNA Repair Drugs Value Chain Figure 67. Manufacturing Cost Structure Figure 68. DNA Repair Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • PARP Inhibitors
  • Other
Applications
  • Oncological
  • Stroke
Companies covered
  • Johnson & Johnson
  • Jiangsu Hengrui Medicine
  • GlaxoSmithKline
  • Tesaro
  • National Institutes of Health
  • National Health Service
  • KuDOS Pharmaceuticals
  • Karyopharm Therapeutics
  • Jonsson Comprehensive Cancer Center
  • German Breast Group
  • Georgetown University
  • Genentech
  • Cambridge University Hospitals NHS Foundation Trust
  • British Columbia Cancer Agency
  • Bristol Myers Squibb
  • ARCAGY/ GINECO GROUP
  • 4SC AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 DNA Repair Drugs Market by Type
  3. 1.2.1 Global DNA Repair Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 PARP Inhibitors
  5. 1.2.3 Other
  6. 1.3 DNA Repair Drugs Market by Application
  7. 1.3.1 Global DNA Repair Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Oncological
  9. 1.3.3 Stroke
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 DNA Repair Drugs Market Dynamics
  1. 2.1 DNA Repair Drugs Industry Trends
  2. 2.2 DNA Repair Drugs Industry Drivers
  3. 2.3 DNA Repair Drugs Industry Opportunities and Challenges
  4. 2.4 DNA Repair Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global DNA Repair Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global DNA Repair Drugs Revenue by Region
  3. 3.2.1 Global DNA Repair Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global DNA Repair Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global DNA Repair Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global DNA Repair Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global DNA Repair Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global DNA Repair Drugs Sales by Region
  9. 3.4.1 Global DNA Repair Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global DNA Repair Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global DNA Repair Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global DNA Repair Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global DNA Repair Drugs Revenue by Manufacturers
  2. 4.1.1 Global DNA Repair Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global DNA Repair Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global DNA Repair Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global DNA Repair Drugs Sales by Manufacturers
  6. 4.2.1 Global DNA Repair Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global DNA Repair Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global DNA Repair Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global DNA Repair Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global DNA Repair Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global DNA Repair Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global DNA Repair Drugs Manufacturers, Product Type & Application
  13. 4.7 Global DNA Repair Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global DNA Repair Drugs Market CR5 and HHI
  16. 4.8.2 2025 DNA Repair Drugs Tier 1, Tier 2, and Tier 3
5 DNA Repair Drugs Market by Type
  1. 5.1 Global DNA Repair Drugs Revenue by Type
  2. 5.1.1 Global DNA Repair Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global DNA Repair Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global DNA Repair Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global DNA Repair Drugs Sales by Type
  6. 5.2.1 Global DNA Repair Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global DNA Repair Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global DNA Repair Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global DNA Repair Drugs Price by Type
6 DNA Repair Drugs Market by Application
  1. 6.1 Global DNA Repair Drugs Revenue by Application
  2. 6.1.1 Global DNA Repair Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global DNA Repair Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global DNA Repair Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global DNA Repair Drugs Sales by Application
  6. 6.2.1 Global DNA Repair Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global DNA Repair Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global DNA Repair Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global DNA Repair Drugs Price by Application
7 Company Profiles
  1. 7.1 Johnson & Johnson
  2. 7.1.1 Johnson & Johnson Company Information
  3. 7.1.2 Johnson & Johnson Business Overview
  4. 7.1.3 Johnson & Johnson DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Johnson & Johnson DNA Repair Drugs Product Portfolio
  6. 7.1.5 Johnson & Johnson Recent Developments
  7. 7.2 Jiangsu Hengrui Medicine
  8. 7.2.1 Jiangsu Hengrui Medicine Company Information
  9. 7.2.2 Jiangsu Hengrui Medicine Business Overview
  10. 7.2.3 Jiangsu Hengrui Medicine DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Jiangsu Hengrui Medicine DNA Repair Drugs Product Portfolio
  12. 7.2.5 Jiangsu Hengrui Medicine Recent Developments
  13. 7.3 GlaxoSmithKline
  14. 7.3.1 GlaxoSmithKline Company Information
  15. 7.3.2 GlaxoSmithKline Business Overview
  16. 7.3.3 GlaxoSmithKline DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 GlaxoSmithKline DNA Repair Drugs Product Portfolio
  18. 7.3.5 GlaxoSmithKline Recent Developments
  19. 7.4 Tesaro
  20. 7.4.1 Tesaro Company Information
  21. 7.4.2 Tesaro Business Overview
  22. 7.4.3 Tesaro DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Tesaro DNA Repair Drugs Product Portfolio
  24. 7.4.5 Tesaro Recent Developments
  25. 7.5 National Institutes of Health
  26. 7.5.1 National Institutes of Health Company Information
  27. 7.5.2 National Institutes of Health Business Overview
  28. 7.5.3 National Institutes of Health DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 National Institutes of Health DNA Repair Drugs Product Portfolio
  30. 7.5.5 National Institutes of Health Recent Developments
  31. 7.6 National Health Service
  32. 7.6.1 National Health Service Company Information
  33. 7.6.2 National Health Service Business Overview
  34. 7.6.3 National Health Service DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 National Health Service DNA Repair Drugs Product Portfolio
  36. 7.6.5 National Health Service Recent Developments
  37. 7.7 KuDOS Pharmaceuticals
  38. 7.7.1 KuDOS Pharmaceuticals Company Information
  39. 7.7.2 KuDOS Pharmaceuticals Business Overview
  40. 7.7.3 KuDOS Pharmaceuticals DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 KuDOS Pharmaceuticals DNA Repair Drugs Product Portfolio
  42. 7.7.5 KuDOS Pharmaceuticals Recent Developments
  43. 7.8 Karyopharm Therapeutics
  44. 7.8.1 Karyopharm Therapeutics Company Information
  45. 7.8.2 Karyopharm Therapeutics Business Overview
  46. 7.8.3 Karyopharm Therapeutics DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Karyopharm Therapeutics DNA Repair Drugs Product Portfolio
  48. 7.8.5 Karyopharm Therapeutics Recent Developments
  49. 7.9 Jonsson Comprehensive Cancer Center
  50. 7.9.1 Jonsson Comprehensive Cancer Center Company Information
  51. 7.9.2 Jonsson Comprehensive Cancer Center Business Overview
  52. 7.9.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Jonsson Comprehensive Cancer Center DNA Repair Drugs Product Portfolio
  54. 7.9.5 Jonsson Comprehensive Cancer Center Recent Developments
  55. 7.10 German Breast Group
  56. 7.10.1 German Breast Group Company Information
  57. 7.10.2 German Breast Group Business Overview
  58. 7.10.3 German Breast Group DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 German Breast Group DNA Repair Drugs Product Portfolio
  60. 7.10.5 German Breast Group Recent Developments
  61. 7.11 Georgetown University
  62. 7.11.1 Georgetown University Company Information
  63. 7.11.2 Georgetown University Business Overview
  64. 7.11.3 Georgetown University DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Georgetown University DNA Repair Drugs Product Portfolio
  66. 7.11.5 Georgetown University Recent Developments
  67. 7.12 Genentech
  68. 7.12.1 Genentech Company Information
  69. 7.12.2 Genentech Business Overview
  70. 7.12.3 Genentech DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Genentech DNA Repair Drugs Product Portfolio
  72. 7.12.5 Genentech Recent Developments
  73. 7.13 Cambridge University Hospitals NHS Foundation Trust
  74. 7.13.1 Cambridge University Hospitals NHS Foundation Trust Company Information
  75. 7.13.2 Cambridge University Hospitals NHS Foundation Trust Business Overview
  76. 7.13.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product Portfolio
  78. 7.13.5 Cambridge University Hospitals NHS Foundation Trust Recent Developments
  79. 7.14 British Columbia Cancer Agency
  80. 7.14.1 British Columbia Cancer Agency Company Information
  81. 7.14.2 British Columbia Cancer Agency Business Overview
  82. 7.14.3 British Columbia Cancer Agency DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 British Columbia Cancer Agency DNA Repair Drugs Product Portfolio
  84. 7.14.5 British Columbia Cancer Agency Recent Developments
  85. 7.15 Bristol Myers Squibb
  86. 7.15.1 Bristol Myers Squibb Company Information
  87. 7.15.2 Bristol Myers Squibb Business Overview
  88. 7.15.3 Bristol Myers Squibb DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Bristol Myers Squibb DNA Repair Drugs Product Portfolio
  90. 7.15.5 Bristol Myers Squibb Recent Developments
  91. 7.16 ARCAGY/ GINECO GROUP
  92. 7.16.1 ARCAGY/ GINECO GROUP Company Information
  93. 7.16.2 ARCAGY/ GINECO GROUP Business Overview
  94. 7.16.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 ARCAGY/ GINECO GROUP DNA Repair Drugs Product Portfolio
  96. 7.16.5 ARCAGY/ GINECO GROUP Recent Developments
  97. 7.17 4SC AG
  98. 7.17.1 4SC AG Company Information
  99. 7.17.2 4SC AG Business Overview
  100. 7.17.3 4SC AG DNA Repair Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 4SC AG DNA Repair Drugs Product Portfolio
  102. 7.17.5 4SC AG Recent Developments
8 North America
  1. 8.1 North America DNA Repair Drugs Market Size by Type
  2. 8.1.1 North America DNA Repair Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America DNA Repair Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America DNA Repair Drugs Price by Type (2021-2032)
  5. 8.2 North America DNA Repair Drugs Market Size by Application
  6. 8.2.1 North America DNA Repair Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America DNA Repair Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America DNA Repair Drugs Price by Application (2021-2032)
  9. 8.3 North America DNA Repair Drugs Market Size by Country
  10. 8.3.1 North America DNA Repair Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America DNA Repair Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America DNA Repair Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe DNA Repair Drugs Market Size by Type
  2. 9.1.1 Europe DNA Repair Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe DNA Repair Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe DNA Repair Drugs Price by Type (2021-2032)
  5. 9.2 Europe DNA Repair Drugs Market Size by Application
  6. 9.2.1 Europe DNA Repair Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe DNA Repair Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe DNA Repair Drugs Price by Application (2021-2032)
  9. 9.3 Europe DNA Repair Drugs Market Size by Country
  10. 9.3.1 Europe DNA Repair Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe DNA Repair Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe DNA Repair Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China DNA Repair Drugs Market Size by Type
  2. 10.1.1 China DNA Repair Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China DNA Repair Drugs Sales by Type (2021-2032)
  4. 10.1.3 China DNA Repair Drugs Price by Type (2021-2032)
  5. 10.2 China DNA Repair Drugs Market Size by Application
  6. 10.2.1 China DNA Repair Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China DNA Repair Drugs Sales by Application (2021-2032)
  8. 10.2.3 China DNA Repair Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia DNA Repair Drugs Market Size by Type
  2. 11.1.1 Asia DNA Repair Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia DNA Repair Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia DNA Repair Drugs Price by Type (2021-2032)
  5. 11.2 Asia DNA Repair Drugs Market Size by Application
  6. 11.2.1 Asia DNA Repair Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia DNA Repair Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia DNA Repair Drugs Price by Application (2021-2032)
  9. 11.3 Asia DNA Repair Drugs Market Size by Country
  10. 11.3.1 Asia DNA Repair Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia DNA Repair Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia DNA Repair Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA DNA Repair Drugs Market Size by Type
  2. 12.1.1 SAMEA DNA Repair Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA DNA Repair Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA DNA Repair Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA DNA Repair Drugs Market Size by Application
  6. 12.2.1 SAMEA DNA Repair Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA DNA Repair Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA DNA Repair Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA DNA Repair Drugs Market Size by Country
  10. 12.3.1 SAMEA DNA Repair Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA DNA Repair Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA DNA Repair Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 DNA Repair Drugs Value Chain Analysis
  2. 13.1.1 DNA Repair Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 DNA Repair Drugs Production Mode & Process
  6. 13.2 DNA Repair Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 DNA Repair Drugs Distributors
  9. 13.2.3 DNA Repair Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst